Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-312.76	-547.03	-892.87	-2,106	-1,837
Depreciation & Amortization	58.99	63.02	70.51	42.55	29.08
Stock-Based Compensation	81.55	112.34	229.88	1,931	1,606
Other Adjustments	45.26	141.75	267.14	-82.01	9.27
Change in Receivables	-1.47	-4.73	50.07	55.02	-114.09
Changes in Accounts Payable	-2.99	4.77	-1.18	-10.84	-2.25
Changes in Accrued Expenses	10.38	-40.44	16.9	-39.64	44.8
Changes in Unearned Revenue	-32.39	-68.65	-35.92	-36.42	-10.5
Changes in Other Operating Activities	-17.61	19.37	-0.03	-5.13	20.51
Operating Cash Flow	-171.06	-319.59	-295.5	-252.2	-253.82
Capital Expenditures	-7.67	-62.54	-40.8	-52.27	-56.52
Sale of Property, Plant & Equipment	0.57	0.65	4.43	-	-
Purchases of Investments	-418.63	-	-	-3.69	-5
Proceeds from Sale of Investments	185.38	4.52	-	-	-
Payments for Business Acquisitions	-	-5.4	-	74.73	-12.04
Other Investing Activities	0.05	0.54	-44.32	-86.16	0.3
Investing Cash Flow	-240.29	-62.24	-80.69	-67.39	-73.26
Issuance of Common Stock	19.47	0.08	0.09	99.54	1,510
Repurchase of Common Stock	-	-	-0.02	-0.98	-34.46
Net Common Stock Issued (Repurchased)	19.47	0.08	0.07	98.56	1,475
Other Financing Activities	-1.69	-1.82	-3.29	-3.23	58.81
Financing Cash Flow	17.78	-1.74	-3.22	95.34	1,534
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.2	-0.28	-0.59	0.91	-0.02
Net Cash Flow	-393.37	-383.84	-380	-223.35	1,207
Free Cash Flow	-178.72	-382.13	-336.3	-304.47	-310.34
FCF Margin	-105.04%	-168.31%	-133.74%	-63.74%	-98.89%
Free Cash Flow Per Share	-3.22	-7.36	-6.92	-7.25	-9.13
Levered Free Cash Flow	-304.05	-631.5	-883.39	-2,207	-1,805
Unlevered Free Cash Flow	-305.73	-643.73	-854.86	-2,295	-1,802

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q